The tool that makes this possible is the beam profiler, which captures a two-dimensional plot of the intensity of a laser beam. Although many people might imagine that the power density of a laser ...
What risks are associated with the safety profile of Beam's therapies? The safety profile of Beam's base editing therapies remains a critical concern for investors and regulators alike.
Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results. Cathie Wood, CEO of ARK Invest, is doubling ...
MKS Instruments, Inc., a global provider of enabling technologies that transform our world, has announced the Ophir® ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data ...
Beam Therapeutics (BEAM) announced the company will encore data from the BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease in ...